Passage Bio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LYNX1 CAPITAL MANAGEMENT LP | 02/14/2025 | 9.26 M | $5.25 M | 9.85% | 14.99% |
ORBIMED ADVISORS LLC | 02/14/2025 | 7.40 M | $4.20 M | -24.62% | 11.99% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 6.10 M | $3.46 M | 0.00% | 9.88% |
NEW LEAF VENTURE PARTNERS, L.L.C. | 02/13/2025 | 2.50 M | $1.42 M | 0.00% | 4.04% |
02/10/2025 | 2.46 M | $1.63 M | 0.00% | 3.98% | |
VANGUARD GROUP INC | 02/11/2025 | 2.07 M | $1.17 M | 0.00% | 3.35% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.50 M | $850,650 | 0.00% | 2.43% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.38 M | $783,435 | -0.82% | 2.24% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 942,900 | $533,000 | -1.91% | 1.53% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 722,296 | $409,614 | 0.08% | 1.17% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 556,142 | $315,388 | 0.00% | 0.90% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 531,565 | $301,521 | 4.33% | 0.86% |
SHAY CAPITAL LLC | 02/14/2025 | 225,261 | $127,746 | 144.17% | 0.36% |
FIDUCIARY TRUST CO | 02/14/2025 | 215,000 | $121,927 | 0.00% | 0.35% |
STATE STREET CORP | 02/14/2025 | 156,773 | $88,906 | 26.56% | 0.25% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 148,607 | $84,275 | -9.31% | 0.24% |
RBF CAPITAL, LLC | 02/14/2025 | 142,807 | $80,986 | 0.00% | 0.23% |
JANE STREET GROUP, LLC | 02/14/2025 | 78,190 | $44,341 | 537.19% | 0.13% |
SQUAREPOINT OPS LLC | 02/14/2025 | 64,099 | $36,351 | 129.52% | 0.10% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 54,479 | $30,890 | 983.08% | 0.09% |
DLK INVESTMENT MANAGEMENT, LLC | 01/16/2025 | 53,000 | $30,056 | -17.19% | 0.09% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 49,364 | $27,994 | -49.65% | 0.08% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 27,068 | $15,350 | -0.01% | 0.04% |
GROUND SWELL CAPITAL, LLC | 02/14/2025 | 25,424 | $14,418 | 100.00% | 0.04% |
FMR LLC | 02/13/2025 | 21,054 | $11,940 | -7.87% | 0.03% |
HIGHTOWER ADVISORS, LLC | 02/07/2025 | 15,523 | $8,803 | -5.23% | 0.03% |
HRT FINANCIAL LP | 02/14/2025 | 13,850 | $7,000 | 100.00% | 0.02% |
BARCLAYS PLC | 02/13/2025 | 13,153 | $7,000 | 0.00% | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 10,500 | $5,985 | 100.00% | 0.02% |
VIRTU FINANCIAL LLC | 02/11/2025 | 10,286 | $6,000 | 100.00% | 0.02% |
ATRIA WEALTH SOLUTIONS, INC. | 01/31/2025 | 10,000 | $5,671 | 100.00% | 0.02% |
MAI CAPITAL MANAGEMENT | 02/14/2025 | 4,000 | $2,269 | 100.00% | 0.01% |
02/06/2025 | 2,369 | $1,343 | 100.00% | 0.00% | |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1,770 | $1,239 | 0.00% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 273 | $155 | 0.00% | 0.00% |
LRI INVESTMENTS, LLC | 02/14/2025 | 225 | $128 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 186 | $105 | 100.00% | 0.00% |
HARBOUR INVESTMENTS, INC. | 02/10/2025 | 60 | $34 | 0.00% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 02/10/2025 | 50 | $28 | 100.00% | 0.00% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 47 | $27 | 0.00% | 0.00% |
UBS GROUP AG | 02/14/2025 | 2 | $1 | 100.00% | 0.00% |
FEDERATED HERMES, INC. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
CRESSET ASSET MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
NORDWAND ADVISORS, LLC | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
Passage Bio, Inc. institutional Ownership - FAQ's
During the previous two years, 60 institutional investors and hedge funds held shares of Passage Bio, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 9.26 M
ORBIMED ADVISORS LLC: 7.4 M
Vestal Point Capital, LP: 6.1 M
New Leaf Venture Partners, L.L.C.: 2.5 M
VANGUARD GROUP INC: 2.07 M
TANG CAPITAL MANAGEMENT LLC: 1.5 M
60.93% of Passage Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 37.30 M shares in the last 24 months. This purchase volume represents approximately $28.35 M in transactions.